Product Information
LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1084 per EA under NDC 16729045815. Its NADAC has been published 282 times since Feb 3, 2021.
Strength
300 ug/1
Manufacturer
Accord Healthcare Inc.NDC
16729045815
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA212399On Market Since
12/10/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 282 times since Feb 3, 2021, and over the history we have for it it has declined 82.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1084 per EA |
|---|---|
| All-time high | $0.6020 (Feb 10, 2021) |
| All-time low | $0.0715 (Jul 17, 2024) |
| 52-week high | $0.1278 |
| 52-week low | $0.1084 |
| Median price | $0.1406 |
| Average price | $0.1983 |
| Largest weekly change | +78.9% (Aug 21, 2024) |
| Weeks tracked | 282 |
| Tracking since | Feb 3, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Accord Healthcare Inc., is $0.1084 per EA (NDC 16729045815), effective Jun 24, 2026.
How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 82.0%. It has been tracked across 282 weekly CMS publications since Feb 3, 2021.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?
Since Feb 3, 2021, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.6020 (Feb 10, 2021), with a median of $0.1406 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEVOTHYROXINE 300 MCG TABLET, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 300 MCG TABLET?
LEVOTHYROXINE 300 MCG TABLET (NDC 16729045815) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification